Pennsylvania HB 2592: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Status: Referred to Health (as of 2024-09-24)

State: Pennsylvania · Session: 2023-2024 · Bill: HB 2592

Sponsors: Kathy Rapp, Dan Moul, David Zimmerman, Doyle Heffley, Joanne Stehr, Martin Causer, Nancy Guenst, Rob Kauffman

View Pennsylvania HB 2592 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.